Onward Medical N.V.
ONWD.BR
| Exchange: | BR |
| Currency | Euro |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Biotechnology |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Biotechnology |
| Gic Sub Industry: | Biotechnology |
| Description: | Onward Medical N.V., a medical technology company, develops implantable neuro-stimulation Systems and non-invasive systems for electrical stimulation of specific areas of the spinal cord. The company engages in developing ARCEX, a transcutaneous system designed to improve upper extremity strength, function, and other symptoms in people with spinal cord injury (SCI); ARCIM, a minimally invasive implantable system to address blood pressure instability and other symptoms in people with SCI; and ARCBCI, which adds an implantable bran-computer interface to the ARCIM to restore thought-driven movement of the upper and lower limbs. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands. |
| Address: | Schimmelt 2, Eindhoven, Netherlands, NL-5656 |
| Website: | https://www.onwd.com |
| Full Time Employees: | 99 |
| Updated On: | 2024-11-05 |
Highlights
| Market Capitalization: | 229881808 |
| Market Capitalization Mln: | 229.88 |
| EBITDA: | -35098000 |
| Wall Street Target Price: | 13.5 |
| Book Value: | 0.53 |
| Earnings Share: | -1.09 |
| Most Recent Quarter: | 2024-06-30 |
| Operating Margin TTM: | -90.13 |
| Return On Assets TTM: | -0.41 |
| Return On Equity TTM: | -1.33 |
| Revenue TTM: | -188000 |
| Revenue Per Share TTM: | -0.00 |
| Quarterly Revenue Growth YOY: | -0.77 |
| Diluted Eps TTM: | -1.09 |
Valuation
| Price Sales TTM: | 306.58 |
| Price Book MRQ: | 12.06 |
| Enterprise Value: | 206620006 |
| Enterprise Value Ebitda: | -3.15 |
Shares
| Shares Outstanding: | 44628800 |
| Shares Float: | 13627484 |
| Percent Insiders: | 14.40 |
| Percent Institutions: | 27.52 |
Technicals
| Beta: | 0.84 |
| 52 Week High: | 6.58 |
| 52 Week Low: | 1.85 |
| 50 Day MA: | 5.06 |
| 200 Day MA: | 5.00 |
Earnings
| Report Date: | 2023-03-27 |
| Date: | 2022-12-31 |
| Before After Market: | After Market |
| Eps Actual: | -0.56 |
| Eps Difference: | -0.56 |
| Report Date: | 2022-08-28 |
| Date: | 2022-06-30 |
| Before After Market: | Before Market |
| Eps Actual: | -0.53 |
| Eps Difference: | -0.53 |
| Report Date: | 2022-04-24 |
| Date: | 2022-03-31 |
| Before After Market: | Before Market |
| Eps Actual: | -2.27 |
| Eps Difference: | -2.27 |
| Report Date: | 2021-10-13 |
| Date: | 2021-09-30 |
| Before After Market: | After Market |
| Eps Actual: | -0.3 |
| Eps Difference: | -0.3 |
| Date: | 2022-12-31 |
| Eps Actual: | -3.6 |